Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases
- 8 June 2020
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 33 (12), 2520-2533
- https://doi.org/10.1038/s41379-020-0580-6
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumorGenes, Chromosomes and Cancer, 2011
- Hybrid Myxoinflammatory Fibroblastic Sarcoma/Hemosiderotic Fibrolipomatous Tumor: Report of a Case Providing Further Evidence for a Pathogenetic LinkThe American Journal of Surgical Pathology, 2010
- YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomasGenes, Chromosomes and Cancer, 2010
- Management of acral myxoinflammatory fibroblastic sarcomaCancer, 2010
- CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanomaJournal of Cutaneous Pathology, 2010
- Acral myxoinflammatory fibroblastic sarcoma: case series and immunohistochemical analysisJournal of Cutaneous Pathology, 2007
- Acral myxoinflammatory fibroblastic sarcomas: are they all low‐grade neoplasms?Journal of Cutaneous Pathology, 2007
- Role of Coagulation Factor XIII (FXIII) in Angiogenesis and Tissue RepairPathophysiology of Haemostasis and Thrombosis, 2006
- Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid sarcomaLaboratory Investigation, 2005
- Myxoinflammatory fibroblastic sarcoma: A tumor not restricted to acral sitesAnnals of Diagnostic Pathology, 2002